1. Market Research
  2. > All Companies
  3. > Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile

Summary

Laboratory Corporation of America Holdings (LabCorp) is a healthcare diagnostics company. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. The company has a network of 39 primary laboratories and more than 1750 patient service centers. It offers its services to managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies across all the 50 states in the US, the District of Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

The company focuses on expanding its service portfolio through both inorganic and organic approaches. The inorganic approach includes acquisitions which can be reflected from the recent acquisition of Covance. The organic approach includes in-house development of several testing technologies. These concentrated efforts will help the company gain more market share.

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Laboratory Corporation of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 8
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2009 to YTD 2015 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2009 to YTD 2015 11
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2009 to YTD 2015 12
Laboratory Corporation of America Holdings, Medical Equipment, Deal Details 16
Venture Financing 16
Vivify Health Raises Funds in Series B Venture Financing 16
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 17
Flatiron Health Raises US$130 Million In Series B Financing 19
Flatiron Health Raises US$8 Million In Series A Financing 21
Nodality Secures US$15.5 Million In Financing Round 23
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 25
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 27
Partnerships 28
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 28
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 29
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 30
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 31
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 32
Orchid Cellmark Enters Into Worldwide Licensing Agreement With Illumina 33
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 34
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 35
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 36
Emdeon Enters Into Strategic Alliance With LabCorp 37
Duke University Medical Center Enters Into Joint Venture With LabCorp 38
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 39
Monogram Biosciences Extends An Agreement With Pfizer 40
CareDx Terminates Co-Development Agreement with LabCorp 41
University of Minnesota Signs Licensing Agreement With LabCorp 42
Equity Offering 43
Monogram Biosciences Withdraws Public Offering Of Its Common Stock 43
Debt Offering 44
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 44
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 46
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 48
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 50
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 52
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 54
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 56
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 58
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 60
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 62
Asset Transactions 64
Marken Acquires European Kit Building Operation Facility From LabCorp 64
DNA Diagnostics Center Acquires Government Paternity Business From Orchid Cellmark 65
Acquisition 66
LabCorp Acquires Covance for USD6.1 Billion 66
LabCorp Acquires Bode Technology from SolutionPoint 69
LabCorp Acquires LipoScience for USD85.3 Million 70
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 72
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 73
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 75
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 76
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 79
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 81
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 82
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 83
Lab Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 84
Laboratory Corporation of America Holdings - Key Competitors 86
Key Employees 87
Locations And Subsidiaries 88
Head Office 88
Other Locations and Subsidiaries 88
Recent Developments 92
Strategy And Business Planning 92
Feb 20, 2015: LabCorp Plans For Cost Savings 92
Sep 04, 2014: LabCorp's Enlighten Health Launches Innovative Genomics Initiative 93
Jun 03, 2014: Omicia and LabCorp Collaborate to Offer Comprehensive Genomic Analysis Services for Next-Generation Clinical Trials 94
Financial Announcements 95
Feb 20, 2015: Laboratory Corporation of America Holdings Announces 2014 Fourth Quarter and Full Year Results and Provides 2015 Guidance 95
Oct 28, 2014: Laboratory Corporation of America Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance 97
Jul 18, 2014: Laboratory Corporation of America Announces 2014 Second Quarter Results and Increases 2014 EPS Guidance 99
Apr 28, 2014: Laboratory Corporation of America Holdings Announces 2014 First Quarter Results and Updates 2014 Guidance 100
Feb 07, 2014: Laboratory Corporation of America Announces 2013 Fourth Quarter and Full Year Results and Provides 2014 Guidance 102
Corporate Communications 104
Mar 25, 2014: LabCorp Announces Appointment of Chief Financial Officer 104
Government and Public Interest 105
Jan 06, 2014: LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference 105
Jan 06, 2014: LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference 106
Other Significant Developments 107
Jan 29, 2014: Epic Sciences Partners with LabCorp to Accelerate European Clinical Sample Processing for Circulating Tumor Cell Technology 107
Jan 28, 2014: Diasorin Extends Its Relationship With Laboratory Corporation Of America Holdings 108
Jan 21, 2014: Illumina Signs Master Supply Agreement to Provide Next-Generation Sequencing Technologies to LabCorp 109
Appendix 110
Methodology 110
About GlobalData 110
Contact Us 110
Disclaimer 110

List of Tables
Laboratory Corporation of America Holdings, Medical Equipment, Key Facts, 2014 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 8
Laboratory Corporation of America Holdings, Medical Equipment Deals By Type, 2009 to YTD 2015 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 10
Laboratory Corporation of America Holdings, Deals By Market, 2009 to YTD 2015 11
Laboratory Corporation of America Holdings, Medical Equipment, Deals Summary, 2009 to YTD 2015 12
Vivify Health Raises Funds in Series B Venture Financing 16
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 17
Flatiron Health Raises US$130 Million In Series B Financing 19
Flatiron Health Raises US$8 Million In Series A Financing 21
Nodality Secures US$15.5 Million In Financing Round 23
CancerGuide Diagnostics Raises Additional US$0.7 Million In Financing Round 25
CancerGuide Secures US$10.5 Million In First Tranche Of Venture Financing 27
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 28
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 29
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 30
Merck Enters Into Licensing Agreement With Lab Corporation of America Holdings 31
TrovaGene Enters Into Licensing Agreement With Lab Corporation of America Holdings And InVivoScribe Technologies 32
Orchid Cellmark Enters Into Worldwide Licensing Agreement With Illumina 33
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 34
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 35
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 36
Emdeon Enters Into Strategic Alliance With LabCorp 37
Duke University Medical Center Enters Into Joint Venture With LabCorp 38
CancerGuide Diagnostics Enters Into An Agreement With Lab Corporation of America 39
Monogram Biosciences Extends An Agreement With Pfizer 40
CareDx Terminates Co-Development Agreement with LabCorp 41
University of Minnesota Signs Licensing Agreement With LabCorp 42
Monogram Biosciences Withdraws Public Offering Of Its Common Stock 43
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 44
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 46
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 48
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 50
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 52
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 54
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 56
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 58
LabCorp Completes An Underwritten Public Offering Of 3.125% Senior Notes Due 2016 For US$325 Million 60
LabCorp Completes An Underwritten Public Offering Of 4.625% Senior Notes Due 2020 For US$600 Million 62
Marken Acquires European Kit Building Operation Facility From LabCorp 64
DNA Diagnostics Center Acquires Government Paternity Business From Orchid Cellmark 65
LabCorp Acquires Covance for USD6.1 Billion 66
LabCorp Acquires Bode Technology from SolutionPoint 69
LabCorp Acquires LipoScience for USD85.3 Million 70
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 72
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 73
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 75
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 76
Lab Corporation of America Completes Acquisition Of Genzyme Genetics From Genzyme 79
Lab Corporation Acquires DCL Medical Labs From Thompson Street Capital Partners 81
LabCorp Sells Minority Stake In Ontario, Canada Joint Venture 82
LabCorp Completes Acquisition Of Minority Stake In Ontario, Canada Joint Venture 83
Lab Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 84
Laboratory Corporation of America Holdings, Key Competitors 86
Laboratory Corporation of America Holdings, Key Employees 87
Laboratory Corporation of America Holdings, Other Locations 88
Laboratory Corporation of America Holdings, Subsidiaries 90

List of Figures
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Year, 2009 to YTD 2015 8
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Type, 2009 to YTD 2015 9
Laboratory Corporation of America Holdings, Medical Equipment, Deals By Region, 2009 to YTD 2015 10
Laboratory Corporation of America Holdings, Medical Equipment, Deals by Market, 2009 to YTD 2015 11

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.